The heat shock proteins (HSPs) 70 and HSP 27 expression in patients with non-small cell lung cancer (NSCLC) was studied and the relationship between HSP 70 and HSP 27 with the clinicopathological features of NSCLC was investigated. The expression of HSP 70 and HSP 27 was detected in tumor tissues from 60 patients with NSCLC by S-P immunohistochemistry. The findings were analyzed in combination with the histological types, histopathological differentiation, lymph node metastasis, patients clinical stages, smoking history and gender. The results showed that of the 60 NSCLC tissue specimens studied, the immunoreactivity of HSP 70 and HSP 27 was detected in 47 (78.3%) and 43 (71.7%) specimens, respectively. A positive correlation was found between the overexpression of HSP 70 and HSP 27. The histopathological differentiation, lymph node metastasis, clinical stages and smoking history were correlated to the expression of HSP 70, but not to the expression of HSP 27. No statistical significance was observed in histological types and gender with respect to both HSP 70 and HSP 27 expression. It is suggested that the HSP 70 expression is a powerful and significant prognostic indicator and is related to histopathological differentiation, lymph node metastasis, patients' clinical stages, smoking history, whereas HSP 27 expression is not.
non-small cell lung cancer heat shock protein 70 and 27 immunohistochemistry
This is a preview of subscription content, log in to check access.
Lazaris A C, Theodoropoulos GE, Davaris P Set al. Heat shock protein 70 and HLA-DR molecules tissue expression: prognostic implications in colorectal cancer. Dis Colon Rectum, 1995, 38:739PubMedCrossRefGoogle Scholar
Michils A, Redivo M, de Beyl V Z. Increased expression of high but not low molecular weight heat shock proteins in respectable lung carcinoma. Lung Cancer, 2001, 33:59PubMedCrossRefGoogle Scholar
Ciocca D R, Fuqua S A, Lock-Lim Set al. Response of human breast cancer cells to heat shock and chemotherapeutic drugs. Cancer Res, 1992, 52:3648PubMedGoogle Scholar
Nanbu K, Konishi I, Komatsu Tet al. Expression of heat shock proteins HSP70 and HSP90 in endometrial carcinomas: correlation with clinicopathology, sex steroid receptor status and p53 protein expression. Cancer, 1996, 77:330PubMedCrossRefGoogle Scholar
Gress T M, Muller-Pillasch F, Weber Cet al. Differential expression of heat shock proteins in pancreatic carcinoma. Cancer Res, 1994, 54:547PubMedGoogle Scholar
Vayssier-Taussat M, Camilli T, Aron Yet al. Effects of tobacco smoke and benzo[a]pyrene on human endothelial cell and monocyte stress responses. J Physiol Heart Circ Physiol, 2001, 280:1293Google Scholar
Oesterreich S, Hilsenbeck S G, Ciocca D R. The small heat shock protein HSP27 is not an independent prognostic marker in axiallary lymph node-negative breast cancer patients. Clin Cancer Res, 1996, 2:1199PubMedGoogle Scholar
Cornford P A, Dodson A R, Parsons K F. Heat shock protein expression independently predicts clinical outcome in prostate cancer. Cancer Res, 2000, 60:7099PubMedGoogle Scholar
Ehrenfried J A, Herron B E, Towsend C M Jr. Heat shock proteins are differentially expressed in human gastrointestinal cancer. Surg Oncol, 1995, 4,197PubMedCrossRefGoogle Scholar
Langdon S P, Rabiasz G J, Hirst G Let al. Expression of heat-shock protein HSP27 in human ovarian cancer, Clin Cancer Res, 1995, 1:1603PubMedGoogle Scholar
Hsu P L, Hsu S M. Abundance of heat shock proteins (HSP89, HSP60, and HSP27) in malignant cells of Hodgkin's disease. Cancer Res, 1998, 58:5507PubMedGoogle Scholar
King K L, Li A F, Chau G Y. Prognostic significance of heat shock protein 27 expression in hepatocellular carcinoma and its relation to histologic grading and survival. Cancer, 2000, 88:2464PubMedCrossRefGoogle Scholar